Complement Your Mohs Practice with a Non-Invasive Treatment Option
For patients that are not surgical candidates, the SRT from Sensus Healthcare offers a non-invasive treatment option with cure rates of 98.9%. Let's chat to see how it can work in you rpractice.
Why the SRT from Sensus Healthcare?
Adopt a highly effective, non-invasive treatment option to complement Mohs so you never have to choose between providing excellent clinical care and protecting your bottom line.
The SRT-100™ is designed to complement your existing surgical schedule, not compete with it. It allows you to offer a 98.9% cure rate for the exact patients who cannot—or will not—undergo surgery.
Equipped with high-frequency ultrasound imaging, you can truly "see and treat" the lesion, tracking the cancer's depth and reduction in real-time.
Elevate Your Practice Today.
Offer the gold standard in non-invasive treatment for non-melanoma skin cancers and keloids.
SRT has given us an additional option in the treatment of non-melanoma skin cancer. Patients love the fact that we can treat skin cancer without surgery.
- Dr. Johnny Gurgen
It's fantastic that I can offer SRT as part of my treatment protocol with confidence that I finally have a reliable procedure to help them.
- Dr. Sandra Lee (Pimple Popper)
Incorporating SRT into my practice has been a great decision. It has given many of my patients safe, effective, cosmetically appealing, non-surgical treatment for skin cancers.
- Dr. Megan Davidson, DO
SRT has given us an additional option in the treatment of non-melanoma skin cancer. Patients love the fact that we can treat skin cancer without surgery.
- Dr. Johnny Gurgen
Use the 2026 CMS Codes for SRT to maximize reimbursement.
Leverage Sensus Healthcare Financial Services for a simple pathway to purchase or lease a system.